Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Apr 22;10(9):e30004.
doi: 10.1016/j.heliyon.2024.e30004. eCollection 2024 May 15.

Cerebral large vessels vasculitis following Guillain-Barré syndrome as first clinical manifestations of primary Sjogren's syndrome: A case based - Review

Zakaria Saied  1 , Rania Zouari  1 , Amine Rachdi  2 , Fatma Nabli  2 , Dina Ben Mohamed  1 , Samia Ben Sassi  1
Affiliations
Case Reports

Cerebral large vessels vasculitis following Guillain-Barré syndrome as first clinical manifestations of primary Sjogren's syndrome: A case based - Review

Zakaria Saied et al. Heliyon. .

Abstract

Background: Primary Sjogren's syndrome (pSS) is an autoimmune exocrinopathy in which extraglandular signs of pSS are determinant for the prognosis. Involvement of both peripheral and central nervous system (CNS) are known to be among the sites of high systemic activity in pSS.

Case presentation: We, herein, report a case of a 57-year-old female patient with pSS presenting with typical Guillan-Barré syndrome (GBS), shortly followed by acute headaches accompanied by cortical blindness. Cerebral magnetic resonance imaging (MRI) demonstrated T2 signal abnormalities on the occipital region with narrowing and irregularities of the cerebral arteries, suggestive of CNS vasculitis.Subtle sicca symptoms occurring prior to neurological symptoms by 8 months together with immunological disturbances (anti-SSA, anti-SSB antibodies positivity, type II cryoglobulins positivity, and C4 hypocomplementemia) allowed us to retain the diagnosis of pSS. Recovery of motor symptoms was possible under the combined use of immunoglobulins and corticotherapy during the initial phase. A three-years follow-up confirmed progressive motor recovery and stabilization under 6-months cyclophosphamide cycles relayed by azathioprine therapy.

Conclusions: Neurological complications can be inaugural in lead to urgent investigations and treatment. Peripheral and central neurological manifestations can coexist. The approach should integrate careful clinical assessment, as well as radiological and immunological findings.

Keywords: Central nervous system; Guillan-Barré syndrome; Primary Sjogren syndrome; Vasculitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
(a) Initial magnetic resonance (MRI) of the brain. The initial MRI scan showed hyperintenses white matter lesions involving right occipital regions and left subcortical occipital, periventricular regions in the axial T2 Flair ponderation (Arrows). (b) The initial MRI scan of the brain, axial T2 Flair ponderation showed hyperintense lesion involving the left parietal lobe (Arrow). (c) The initial Angio-MRI 3D-TOF (time-of-flight) showed the narrowing of the M 1 and M 3 segments of the right middle cerebral artery and M 1 segment of the left middle cerebral artery (Arrows).
See this image and copyright information in PMC

References

    1. Alunno A., Carubbi F., Bartoloni E., Cipriani P., Giacomelli R., Gerli R. The kaleidoscope of neurological manifestations in primary Sjögren’s syndrome. Clin. Exp. Rheumatol. 2019;37(118):192–198. 3. PMID: 31464676 [PubMed] - PubMed
    1. Baldini C., Pepe P., Quartuccio L., Priori R., Bartoloni E., Alunno A., et al. Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients. Rheumatology. 2014;53(5):839–844. doi: 10.1093/rheumatology/ket427. - DOI - PubMed
    1. Carvajal Alegria G., Guellec D., Mariette X., Gottenberg J.E., Dernis E., Dubost J.J., et al. Epidemiology of neurological manifestations in Sjögren’s syndrome: data from the French ASSESS Cohort. RMD Open. 2016;2(1) doi: 10.1136/rmdopen-2015-000179. - DOI - PMC - PubMed
    1. Tobón G.J., Pers J.O., Devauchelle-Pensec V., Youinou P. Neurological disorders in primary Sjögren's syndrome. Autoimmune Dis. 2012;2012 doi: 10.1155/2012/645967/. - DOI - PMC - PubMed
    1. Massara A., Bonazza S., Castellino G., Caniatti L., Trotta F., Borrelli M., et al. Central nervous system involvement in Sjögren’s syndrome: unusual, but not unremarkable--clinical, serological characteristics and outcomes in a large cohort of Italian patients. Rheumatology. 2010;49(8):1540–1549. doi: 10.1093/rheumatology/keq111. - DOI - PubMed

Publication types